Blake, Cassels & Graydon LLP
Blake, Cassels & Graydon LLP’s multidisciplinary cannabis practice covers a broad range of transactional, regulatory and contentious work, with significant expertise in cross-border matters. Montreal-based corporate and commercial partner Tricia Kuhl co-heads the national group and recently advised Aphelion Real Estate on its C$11.5m acquisition of the shares and debt of 10252832 Canada (a subsidiary of Canopy Growth). Vancouver-based department co-head Kathleen Keilty is also noted for her experience in representing cannabis companies and investors on M&A and corporate finance transactions. Montreal-based associate Renée Tousignant provides support on IP, corporate, and commercial law issues.
Legal 500 Editorial commentary
Key clients
- Rose Lifescience
- PricewaterhouseCoopers
- Globe-Cann. Worldwide Cannabis Consultants
- Aphelion Real Estate (LB Becker Consulting)
- Flower One Restructuring
- Willow Biosciences
- RIV Capital
- Canadian Securities Exchange
- L5 Capital
Work highlights
- Advised Flower One Holdings, FO Labour Management and Flower One Corp on all aspects of the restructuring of Flower One.
- Advised RIV Capital on the Canadian corporate, securities and tax aspects of its acquisition of Etain.
- Provided commercial law advice to Rose Lifescience in connection with cannabis distribution, marketing and sale.
Practice head
The lawyer(s) leading their teams.
Tricia Kuhl, Kathleen Keilty